<DOC>
	<DOC>NCT03039829</DOC>
	<brief_summary>This study will aim to determine whether ingesting creatine nitrate (CrN) at higher doses will differentially affect hemodynamic variables compared to a placebo.</brief_summary>
	<brief_title>Safety of Different Forms of Creatine</brief_title>
	<detailed_description>This study will examine the short-term (7 day) characteristics of ingesting creatine nitrate (CrN) compared to placebo on Chem-15 blood safety, heart rate, blood pressure, heart rate and blood pressure reactivity and self-reported side effects.</detailed_description>
	<criteria>Apparently healthy At least 6 months immediate prior history of resistance training including bench press and leg press or squat A history of treatment for metabolic disease (i.e., diabetes), hypertension, hypotension, thyroid disease, arrhythmias and/or cardiovascular disease Use of prescription medication (birth control is allowed) Pregnant or nursing or plan to become pregnant during the next month Creatine or nitrate use in the last eight weeks History of smoking History of drinking (i.e., 12 drinks per week or more) Use of nonsteroidal antiinflammatory drugs (NSAIDs) including ibuprofen (Advil, Motrin, Nuprin, etc.), indomethacin (Indocin), naproxen (Aleve, Anaprox, Naprelan, Naprosyn), piroxicam (Feldene)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>